BioVenture VoiCes with Chris Garabedian
Today: #103 in Science, Japan on our combined chart.
Chart positions today · Canada
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like BioVenture VoiCes with Chris Garabedian, try…
Ranking history · Canada
Latest episodes
-
Episode 49: Sanofi Ventures' Jason Hafler
October 5, 2026 · 1 hr 6 minJason Hafler shares an overview of the corporate side of the venture world. He describes the unique value that he believes a corporate based VC can bring to the companies it invests in. Plus, his description of cases where investments…
-
Episode 48: Blackstone's Kiran Reddy
September 21, 2026 · 1 hr 8 minBlackstone's Senior Managing Director Kiran Reddy describes his early life and education, and the impact that patient care has had on his approach to investing. He describes notable investments in neuroscience, and a stop at Biogen, before…
-
Episode 47: Ally Bridge's Andrew Lam
September 8, 2026 · 1 hr 5 minAndrew Lam describes his career journey that started with a Doctor of Pharmacy education before working in industry, the investment world, back in industry, and then settling at Ally Bridge. He discusses the successful investments Ally…
-
Episode 46: Catalys Pacific's BT Slingsby
August 24, 2026 · 59 minBT Slingsby describes his education and career abroad, which ultimately led him to found and manage the largest life sciences VC firm in Japan, Catalys Pacific. He describes the dual role of taking assets from Japan and building companies…
-
Episode 45: Catalio Capital Management's George Petrocheilos
August 10, 2026 · 1 hr 10 minGeorge Petrocheilos describes going to school at Hopkins and the relationships formed there that would ultimately lead down the road to specializing in healthcare investing. He discusses starting in life sciences investing at Camden…
Show 7 more episodesShow fewer episodes
-
Episode 44: BainCapital's Adam Koppel
July 27, 2026 · 1 hr 13 minAdam Koppel describes his career path, which included a stop at McKinsey, Biogen, and twice at Bain (where he is now). He descrbies the private equity model they have been on the leading edge of, and his take on where we are in the biotech…
-
Episode 43: Lightstone Venture's Mike Carusi
July 13, 2026 · 1 hr 7 minMike Carusi describes his early life and career, how gaining an appreciation for sales made an impression on him early on, and his philosophy of investing in medical devices - and the similarities and differences between that and investing…
-
Episode 42: Nextech's Thilo Schroeder
June 15, 2026 · 1 hr 5 minHaving been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on…
-
Episode 41: Forbion's Nanna Lüneborg
June 1, 2026 · 1 hr 2 minNanna Luneborg discusses hear career and joining Forbion. She describes the firm's investment approach, and her experience with everything from seed, to private, and to public investing in life sciences. Plus, thoughts on China and AI in…
-
Episode 40: GV's Krishna Yeshwant
May 18, 2026 · 1 hr 19 minHe describes his well-rounded background of studying and working in both software in Silicon Valley and Medicine in Boston, and the start of GV. He describes a conservative start to investing at GV, but also today how Alphabet's scale and…
-
Episode 39: SV Health Investors' Kate Bingham
May 4, 2026 · 1 hr 13 minKate Bingham describes her early life and a serendipitous opportunity to work at Vertex in the early 1990's. She then discusses joining SV Health and describes its investment approaches, the Dementia Discovery Fund, being on the UK's…
-
Episode 38: Deerfield Management's Jason Fuller
April 20, 2026 · 1 hr 6 minHe discusses his education and joining the Langer Lab at MIT, early experiences in venture, including at Third Rock and NEA, and gaining operational experience at Jounce before joining Deerfield. Plus, areas that interest him today and how…